Drug
Telmisartan Amlodipine
Telmisartan Amlodipine: highest development phase Phase 3, developed by Boehringer Ingelheim. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| Telmisartan + amlodipine NCT01975246 | Phase 3 | Hypertension |
| Telmisartan/Amlodipine NCT02259777 | Phase 1 | Healthy |
Latest
No recent events.
Follow Telmisartan Amlodipine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.